Luxembourg vs Sierra Leone: Access to anti-retroviral drugs, male
Luxembourg
83.0%
in 2024
Sierra Leone
82.0%
in 2024
Luxembourg rank
40th
Sierra Leone rank
42nd
Access to anti-retroviral drugs, male over time
- Luxembourg
- Sierra Leone
How they compare
Luxembourg currently reports 83.0% against 82.0% in Sierra Leone, a difference of 1.0%.
Across all 25 years both countries report, Luxembourg has been ahead every year.
Luxembourg ranks 40th and Sierra Leone ranks 42nd of 141 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Luxembourg | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.0% | 1.5% | 43.5% | Luxembourg |
| 2010s | 63.6% | 16.7% | 46.9% | Luxembourg |
| 2020s | 78.8% | 56.8% | 22.0% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Luxembourg or Sierra Leone?
- Luxembourg, at 83.0% against 82.0% in Sierra Leone as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Luxembourg and Sierra Leone?
- 1.0%, with Luxembourg ahead.
- How many years of comparable data are there for Luxembourg and Sierra Leone?
- 25 years are reported by both, from 2000 to 2024.
- How do Luxembourg and Sierra Leone rank globally for access to anti-retroviral drugs, male?
- Luxembourg ranks 40th and Sierra Leone ranks 42nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.